177 related articles for article (PubMed ID: 31934218)
1. Primary hepatic follicular lymphoma: a case report and literature review.
Xu J; Hu S; Li S; Gao Y; Wang W; Zhou X; Cheng X; Zheng Q
Int J Clin Exp Pathol; 2019; 12(9):3671-3674. PubMed ID: 31934218
[TBL] [Abstract][Full Text] [Related]
2. Primary hepatic follicular lymphoma : a case report and discussion of chemotherapy and favorable outcomes.
Gomyo H; Kagami Y; Kato H; Kawase T; Ohshiro A; Oyama T; Kamiya Y; Taji H; Nakamura S; Ogura M; Morishima Y
J Clin Exp Hematop; 2007 Nov; 47(2):73-7. PubMed ID: 18040146
[TBL] [Abstract][Full Text] [Related]
3. Pediatric-Type Follicular Lymphoma in the Dura: A Case Report and Literature Review.
Yamaguchi J; Kato S; Iwata E; Aoki K; Kabeya R; Natsume A; Wakabayashi T
World Neurosurg; 2018 Jul; 115():176-180. PubMed ID: 29678710
[TBL] [Abstract][Full Text] [Related]
4. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.
Watanabe T; Tobinai K; Wakabayashi M; Morishima Y; Kobayashi H; Kinoshita T; Suzuki T; Yamaguchi M; Ando K; Ogura M; Taniwaki M; Uike N; Yoshino T; Nawano S; Terauchi T; Hotta T; Nagai H; Tsukasaki K;
Lancet Haematol; 2018 Nov; 5(11):e520-e531. PubMed ID: 30389034
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
6. [Primary renal lymphoma: a clinical analysis of 5 cases].
Lu L; Shi HZ; Xiao ZJ; Wang D; Li CL
Zhonghua Yi Xue Za Zhi; 2018 May; 98(18):1443-1445. PubMed ID: 29804410
[No Abstract] [Full Text] [Related]
7. Primary hepatic lymphoma of MALT type mimicking hepatic adenoma treated by hepatectomy: a case report and literature review.
Wang RL; Wang J; Li YS; Wang Y; Su Q
Front Surg; 2023; 10():1169455. PubMed ID: 37251580
[TBL] [Abstract][Full Text] [Related]
8. Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.
Robak T; Jin J; Pylypenko H; Verhoef G; Siritanaratkul N; Drach J; Raderer M; Mayer J; Pereira J; Tumyan G; Okamoto R; Nakahara S; Hu P; Appiani C; Nemat S; Cavalli F;
Lancet Oncol; 2018 Nov; 19(11):1449-1458. PubMed ID: 30348538
[TBL] [Abstract][Full Text] [Related]
9. Primary hepatic lymphoma: A rare case report.
Mehta N; Jayapal L; Goneppanavar M; Nelamangala Ramakrishnaiah VP
JGH Open; 2019 Jun; 3(3):261-263. PubMed ID: 31276045
[TBL] [Abstract][Full Text] [Related]
10. Diffuse large B-cell lymphoma presenting as a sacral tumor. Report of two cases.
Liu JK; Kan P; Schmidt MH
Neurosurg Focus; 2003 Aug; 15(2):E10. PubMed ID: 15350041
[TBL] [Abstract][Full Text] [Related]
11. Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.
Hüttmann A; Rekowski J; Müller SP; Hertenstein B; Franzius C; Mesters R; Weckesser M; Kroschinsky F; Kotzerke J; Ganser A; Bengel FM; La Rosée P; Freesmeyer M; Höffkes HG; Hertel A; Behringer D; Prange-Krex G; Griesshammer M; Holzinger J; Wilop S; Krohn T; Raghavachar A; Maschmeyer G; Brink I; Schroers R; Gaska T; Bernhard H; Giagounidis A; Schütte J; Dienst A; Hautzel H; Naumann R; Klein A; Hahn D; Pöpperl G; Grube M; Marienhagen J; Schwarzer A; Kurch L; Höhler T; Steiniger H; Nückel H; Südhoff T; Römer W; Brinkmann M; Ose C; Alashkar F; Schmitz C; Dürig J; Hoelzer D; Jöckel KH; Klapper W; Dührsen U
Ann Hematol; 2019 Apr; 98(4):897-907. PubMed ID: 30610279
[TBL] [Abstract][Full Text] [Related]
12. Spotlight on rituximab in chronic lymphocytic leukemia, low-grade or follicular lymphoma, and diffuse large B-cell lymphoma.
Keating GM
BioDrugs; 2011 Feb; 25(1):55-61. PubMed ID: 21222497
[TBL] [Abstract][Full Text] [Related]
13. Follicular lymphoma-related colitis resembling ulcerative colitis.
Zenda T; Nakagawa N; Maruyama H; Endo T; Higashi K; Yamamoto J; Komai K; Watanabe K; Araki I
Clin J Gastroenterol; 2017 Apr; 10(2):147-153. PubMed ID: 28013449
[TBL] [Abstract][Full Text] [Related]
14. Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy.
Lee S; Yamauchi T; Ishii N; Hashimoto T; Kinoshita K; Imamura S; Kamiya K
Int J Hematol; 2017 Dec; 106(6):852-859. PubMed ID: 28791608
[TBL] [Abstract][Full Text] [Related]
15. Primary hepatic marginal zone B cell lymphoma : a case report and review of the literature.
Yu YD; Kim DS; Byun GY; Lee JH; Kim IS; Kim CY; Kim YC; Suh SO
Indian J Surg; 2013 Jun; 75(Suppl 1):331-6. PubMed ID: 24426608
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
[TBL] [Abstract][Full Text] [Related]
17. A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.
Sinha R; Kaufman JL; Khoury HJ; King N; Shenoy PJ; Lewis C; Bumpers K; Hutchison-Rzepka A; Tighiouart M; Heffner LT; Lechowicz MJ; Lonial S; Flowers CR
Cancer; 2012 Jul; 118(14):3538-48. PubMed ID: 22535574
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow infiltration of CD20-negative follicular lymphoma after rituximab therapy: a histological mimicker of hematogones and B-cell acute lymphoblastic leukemia/lymphoma.
Matsuda I; Hirota S
Int J Clin Exp Pathol; 2015; 8(8):9737-41. PubMed ID: 26464748
[TBL] [Abstract][Full Text] [Related]
19. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
20. Primary cardiac lymphoma: clinical, histologic, immunophenotypic, and genotypic features of 5 cases of a rare disorder.
Nascimento AF; Winters GL; Pinkus GS
Am J Surg Pathol; 2007 Sep; 31(9):1344-50. PubMed ID: 17721189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
